2024

1. Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis

   Science Advances , Vol. 10, Núm. 42

2. Biosafety evaluation of etoposide lipid nanomedicines in C. elegans

   Drug Delivery and Translational Research, Vol. 14, Núm. 8, pp. 2158-2169

3. Correction to: Biosafety evaluation of etoposide lipid nanomedicines in C. elegans (Drug Delivery and Translational Research, (2024), 14, 8, (2158-2169), 10.1007/s13346-023-01466-w)

   Drug Delivery and Translational Research

4. Disentangling Anti-Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab

   Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 5, pp. 1304-1313

5. Essential Role of Astrocytes in Learning and Memory

   International Journal of Molecular Sciences, Vol. 25, Núm. 3

6. Formulation Studies with Cyclodextrins for Novel Selenium NSAID Derivatives

   International Journal of Molecular Sciences, Vol. 25, Núm. 3

7. Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice

   Acta Pharmacologica Sinica

8. How to use meropenem in pediatric patients undergoing CKRT? Integrated meropenem pharmacokinetic model for critically ill children

   Antimicrobial Agents and Chemotherapy, Vol. 68, Núm. 6

9. Lipid-based nanosystems: the next generation of cancer immune therapy

   Journal of Hematology and Oncology, Vol. 17, Núm. 1

10. Mechanism-Based Modeling of Perioperative Variations in Hemoglobin Concentration in Patients Undergoing Laparoscopic Surgery

    Anesthesia and Analgesia, Vol. 138, Núm. 1, pp. 141-151

11. Model-Based Bioequivalence Analysis to Assess and Predict the Relative Bioavailability of Valproic Acid Formulations

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 49, Núm. 4, pp. 507-516

12. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab

    Drug Delivery and Translational Research, Vol. 14, Núm. 5, pp. 1189-1205

13. Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics

    Advanced Drug Delivery Reviews, Vol. 208

14. Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 13, Núm. 4, pp. 638-648

15. Rna-loaded nanoparticles for the treatment of hematological cancers

    Advanced Drug Delivery Reviews, Vol. 214

16. Seleno-Warfare against Cancer: Decoding Antitumor Activity of Novel Acylselenoureas and Se-Acylisoselenoureas

    Pharmaceutics, Vol. 16, Núm. 2

17. Structure and activity of amphiphilic PEO-PPO-based polymeric micelles and gels incorporating host–guest complexes of miltefosine as novel formulations for the treatment of leishmaniasis

    Journal of Molecular Liquids, Vol. 400

18. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut

19. Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles

    Frontiers in Immunology, Vol. 15

20. Thermal characterization, polymorphism, and stability evaluation of Se-NSAID derivatives with potent anticancer activity

    Journal of Thermal Analysis and Calorimetry, Vol. 149, Núm. 3, pp. 1015-1028